Toronto, Canada

Anthony Gramolini

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2006-2021

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Inventor Anthony Gramolini - Pioneering Heart Failure Assessment

Introduction

Anthony Gramolini is a notable inventor based in Toronto, Canada, renowned for his contributions to the medical field through innovative inventions. With a portfolio of five patents, his work primarily addresses critical health issues, particularly in the assessment of heart failure.

Latest Patents

Gramolini's latest patent is centered on the "Use of IGFBP-7 in the Assessment of Heart Failure." This patent outlines a method for assessing heart failure in vitro. The process involves measuring the concentration of the marker IGFBP-7 in a sample, and optionally, the concentration of additional markers related to heart failure. The assessment is conducted by comparing the determined concentrations against established values in a reference population. Furthermore, the patent includes the use of IGFBP-7 as a marker protein in the evaluation of heart failure, along with a marker combination comprising IGFBP-7 and a kit designed for measuring IGFBP-7.

Career Highlights

Throughout his career, Anthony Gramolini has worked with esteemed organizations such as Roche Diagnostics Operations, Inc. and the University of Toronto. His experience in these institutions has underpinned his innovative approach to solving complex health issues through the development of effective assessment methods.

Collaborations

During his professional journey, Gramolini has had the opportunity to collaborate with accomplished colleagues including Ursula-Henrike Wienhues-Thelen and Georg Hess. These collaborations have enriched his research and contributed to the advancement of his inventions.

Conclusion

In summary, Anthony Gramolini stands out as a significant figure in the field of medical invention. His latest patent focused on the assessment of heart failure underscores his commitment to addressing pressing health challenges. With his background and collaboration with notable professionals, he continues to make strides in medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…